Literature DB >> 33606739

Effects of pneumoperitoneum on kidney injury biomarkers: A randomized clinical trial.

Marcos Antonio Marton Filho1,2, Rodrigo Leal Alves3, Paulo do Nascimento1, Gabriel Dos Santos Tarquinio4, Paulo Ferreira Mega5, Norma Sueli Pinheiro Módolo1.   

Abstract

BACKGROUND: Increased intra-abdominal pressure causes hemodynamic changes that may affect renal biomarkers.
METHODS: This randomized, single-blind, single-center clinical trial recruited patients undergoing laparoscopic cholecystectomy at a tertiary care center in Brazil. They were randomly allocated to a standard intra-abdominal pressure group (P10-12, 10-12 mm Hg) and a low intra-abdominal pressure group (P6-8, 6-8 mm Hg). The primary outcome was the change in neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C levels measured at the beginning of the procedure (T0), at the end of the procedure (T1), and 24 hours after the procedure (T2). P-values < 0.05 were considered statistically significant.
RESULTS: In total, 64 patients completed the study-33 were given standard pressure and 31 were given low pressure. There was no significant difference in the biomarker between the groups (P = 0.580), but there was a significant difference between the time points with elevation at T1 (P < 0.001). Similar to NGAL, cystatin C had an elevation at T1 in both groups (P = 0.021), but no difference was found when comparing the groups.
CONCLUSIONS: In laparoscopic cholecystectomy, pneumoperitoneum increases NGAL and cystatin C levels intraoperatively, and the use of low-pressure pneumoperitoneum does not change the course of these biomarkers.

Entities:  

Year:  2021        PMID: 33606739     DOI: 10.1371/journal.pone.0247088

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  1 in total

Review 1.  Low-pressure versus standard-pressure pneumoperitoneum in laparoscopic cholecystectomy: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Monica Ortenzi; Giulia Montori; Alberto Sartori; Andrea Balla; Emanuele Botteri; Giacomo Piatto; Gaetano Gallo; Silvia Vigna; Mario Guerrieri; Sophie Williams; Mauro Podda; Ferdinando Agresta
Journal:  Surg Endosc       Date:  2022-04-18       Impact factor: 3.453

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.